← Back to directory

Sebastiaan Engelborghs

Researcher Next ID · RN-021145

Researcher · Medicine

Universitat Autònoma de Barcelona

Cerdanyola del Vallès, Spain

Not currently recruitingFunding unknown
Works count
817
Citation count
50,304
H-index
97
i10-index
355

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Dementia and Cognitive Impairment Research
Alzheimer's disease research and treatments
Amyotrophic Lateral Sclerosis Research
Parkinson's Disease Mechanisms and Treatments
Genetic Associations and Epidemiology

Publications

  • Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

    JAMA Neurology · 2022 · https://doi.org/10.1001/jamaneurol.2021.5216

  • Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Nature Genetics · 2019 · https://doi.org/10.1038/s41588-019-0495-7

  • Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Nature Genetics · 2019 · https://doi.org/10.1038/s41588-019-0358-2

  • Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

    The World Journal of Biological Psychiatry · 2017 · 10.1080/15622975.2017.1375556

  • Consensus guidelines for lumbar puncture in patients with neurological diseases

    Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · https://doi.org/10.1016/j.dadm.2017.04.007

  • Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

    JAMA Psychiatry · 2017 · https://doi.org/10.1001/jamapsychiatry.2017.3391

  • sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

    EMBO Molecular Medicine · 2016 · 10.15252/emmm.201506123

  • A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease

    Acta Neuropathologica · 2016 · https://doi.org/10.1007/s00401-016-1566-9

  • Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

    Alzheimer s & Dementia · 2015 · https://doi.org/10.1016/j.jalz.2015.08.003

  • A Practical Guide to Immunoassay Method Validation

    Frontiers in Neurology · 2015 · 10.3389/fneur.2015.00179

  • Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

    JAMA · 2015 · https://doi.org/10.1001/jama.2015.4668

  • Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

    Brain · 2015 · https://doi.org/10.1093/brain/awv029

  • TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

    Acta Neuropathologica · 2014 · https://doi.org/10.1007/s00401-013-1239-x

  • TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

    Science Translational Medicine · 2014 · https://doi.org/10.1126/scitranslmed.3009093

  • Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration

    Acta Neuropathologica · 2014 · https://doi.org/10.1007/s00401-014-1298-7

  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

    The Lancet Neurology · 2014 · https://doi.org/10.1016/s1474-4422(14)70090-0

  • A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies

    JAMA Neurology · 2013 · 10.1001/jamaneurol.2013.1925

  • Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology

    Molecular Psychiatry · 2013 · 10.1038/mp.2013.1

  • CSF biomarker variability in the Alzheimer's Association quality control program

    Alzheimer s & Dementia · 2013 · 10.1016/j.jalz.2013.01.010

  • The genetics and neuropathology of frontotemporal lobar degeneration

    Acta Neuropathologica · 2012 · 10.1007/s00401-012-1029-x

  • A Pan‐ E uropean Study of the C9orf72 Repeat Associated with FTLD : Geographic Prevalence, Genomic Instability, and Intermediate Repeats

    Human Mutation · 2012 · https://doi.org/10.1002/humu.22244

  • A Pan‐ E uropean Study of the C9orf72 Repeat Associated with FTLD : Geographic Prevalence, Genomic Instability, and Intermediate Repeats

    Human Mutation · 2012 · https://doi.org/10.1002/humu.22244

  • A Pan‐ E uropean Study of the C9orf72 Repeat Associated with FTLD : Geographic Prevalence, Genomic Instability, and Intermediate Repeats

    Human Mutation · 2012 · https://doi.org/10.1002/humu.22244

  • Recommendations to Standardize Preanalytical Confounding Factors in Alzheimer’s and Parkinson’s Disease Cerebrospinal Fluid Biomarkers: An Update

    Biomarkers in Medicine · 2012 · 10.2217/bmm.12.46

  • Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

    Nature Genetics · 2011 · https://doi.org/10.1038/ng.803

  • A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study

    The Lancet Neurology · 2011 · https://doi.org/10.1016/s1474-4422(11)70261-7

  • Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

    Alzheimer s & Dementia · 2011 · 10.1016/j.jalz.2011.07.004

  • APOE and Alzheimer disease: a major gene with semi-dominant inheritance

    Molecular Psychiatry · 2011 · 10.1038/mp.2011.52

  • Monitoring of Physical Activity After Stroke: A Systematic Review of Accelerometry-Based Measures

    Archives of Physical Medicine and Rehabilitation · 2010 · 10.1016/j.apmr.2009.10.025

  • FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

    Acta Neuropathologica · 2010 · https://doi.org/10.1007/s00401-010-0698-6

  • Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

    Nature Genetics · 2009 · https://doi.org/10.1038/ng.439

  • Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

    Nature Genetics · 2009 · https://doi.org/10.1038/ng.440

  • Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

    Nature · 2006 · 10.1038/nature05017

  • The Lateralized Linguistic Cerebellum: A Review and a New Hypothesis

    Brain and Language · 2001 · 10.1006/brln.2001.2569

Current projects

    No projects listed.